3.25.4 html 307 504 1 false 100 0 false 7 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 75020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 75040 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 75050 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 75070 - Disclosure - Cybersecurity Risk Management, Strategy and Governance Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance Cybersecurity Risk Management, Strategy and Governance Notes 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995455 - Disclosure - Organization and Operations Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndOperations Organization and Operations Notes 10 false false R11.htm 995465 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 995475 - Disclosure - Fair Value Measurements Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 995485 - Disclosure - Short-Term Investments Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureShorttermInvestments1 Short-Term Investments Notes 13 false false R14.htm 995495 - Disclosure - Loss per Share Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureLossPerShare Loss per Share Notes 14 false false R15.htm 995505 - Disclosure - Composition of Certain Financial Statement Captions Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptions Composition of Certain Financial Statement Captions Notes 15 false false R16.htm 995515 - Disclosure - Commitments and Contingencies Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 995525 - Disclosure - License Agreements Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureLicenseAgreements License Agreements Notes 17 false false R18.htm 995535 - Disclosure - Term Loan Obligations Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureTermLoanObligations Term Loan Obligations Notes 18 false false R19.htm 995545 - Disclosure - Line of Credit Facility Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureLineOfCreditFacility1 Line of Credit Facility Notes 19 false false R20.htm 995555 - Disclosure - Grant Revenue Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureGrantRevenue Grant Revenue Notes 20 false false R21.htm 995565 - Disclosure - Biocept Asset Acquisitions Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureBioceptAssetAcquisitions1 Biocept Asset Acquisitions Notes 21 false false R22.htm 995575 - Disclosure - Income Taxes Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 22 false false R23.htm 995585 - Disclosure - Employee Benefit Plan Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan Employee Benefit Plan Notes 23 false false R24.htm 995595 - Disclosure - Stockholders' Equity Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 24 false false R25.htm 995605 - Disclosure - Stock-based Compensation Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensation1 Stock-based Compensation Notes 25 false false R26.htm 995615 - Disclosure - Segment Information Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 26 false false R27.htm 995625 - Disclosure - Subsequent Events Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSubsequentEvents1 Subsequent Events Notes 27 false false R28.htm 995635 - Disclosure - Financial Statement Schedules Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureFinancialStatementSchedules Financial Statement Schedules Notes 28 false false R29.htm 995645 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 29 false false R30.htm 995655 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 30 false false R31.htm 995665 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurements 31 false false R32.htm 995675 - Disclosure - Short-Term Investments (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureShorttermInvestmentsTables Short-Term Investments (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureShorttermInvestments1 32 false false R33.htm 995685 - Disclosure - Loss per Share (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureLossPerShareTables Loss per Share (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureLossPerShare 33 false false R34.htm 995695 - Disclosure - Composition of Certain Financial Statement Captions (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptionsTables Composition of Certain Financial Statement Captions (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptions 34 false false R35.htm 995705 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies 35 false false R36.htm 995725 - Disclosure - Income Taxes (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxes 36 false false R37.htm 995735 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockholdersEquity 37 false false R38.htm 995745 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensation1 38 false false R39.htm 995755 - Disclosure - Segment Information (Tables) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSegmentInformation 39 false false R40.htm 995765 - Disclosure - Organization and Operations - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndOperationsAdditionalInformationDetails Organization and Operations - Additional Information (Details) Details 40 false false R41.htm 995775 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 41 false false R42.htm 995785 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Components of Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfComponentsOfCashCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Summary of Reconciliation of Components of Cash, Cash Equivalents, and Restricted Cash (Details) Details 42 false false R43.htm 995795 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) Details 43 false false R44.htm 995805 - Disclosure - Fair Value Measurements - Summary of Key Level 3 Inputs Used in Fair Value (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfKeyLevel3InputsUsedInFairValueDetails Fair Value Measurements - Summary of Key Level 3 Inputs Used in Fair Value (Details) Details 44 false false R45.htm 995815 - Disclosure - Fair Value Measurements - Schedule of Change in Fair Value of Liability (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangeInFairValueOfLiabilityDetails Fair Value Measurements - Schedule of Change in Fair Value of Liability (Details) Details 45 false false R46.htm 995825 - Disclosure - Fair Value Measurements - Summary of Key Level 3 Inputs Used in Valuation of Warrants Liability at Fair Value (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfKeyLevel3InputsUsedInValuationOfWarrantsLiabilityAtFairValueDetails Fair Value Measurements - Summary of Key Level 3 Inputs Used in Valuation of Warrants Liability at Fair Value (Details) Details 46 false false R47.htm 995835 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 47 false false R48.htm 995845 - Disclosure - Short-Term Investments - Summary of Contractual Maturities of Available-for-sale Securities (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfContractualMaturitiesOfAvailableforsaleSecuritiesDetails Short-Term Investments - Summary of Contractual Maturities of Available-for-sale Securities (Details) Details 48 false false R49.htm 995855 - Disclosure - Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share of Common Stock (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareOfCommonStockDetails Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share of Common Stock (Details) Details 49 false false R50.htm 995865 - Disclosure - Loss per Share - Schedule of Antidilutive Securities Excluded from Diluted (Loss) per Share (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromDilutedLossPerShareDetails Loss per Share - Schedule of Antidilutive Securities Excluded from Diluted (Loss) per Share (Details) Details 50 false false R51.htm 995875 - Disclosure - Composition of Certain Financial Statement Captions - Other Current Assets (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptionsOtherCurrentAssetsDetails Composition of Certain Financial Statement Captions - Other Current Assets (Details) Details 51 false false R52.htm 995885 - Disclosure - Composition of Certain Financial Statement Captions - Property and Equipment, Net (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptionsPropertyAndEquipmentNetDetails Composition of Certain Financial Statement Captions - Property and Equipment, Net (Details) Details 52 false false R53.htm 995895 - Disclosure - Composition of Certain Financial Statement Captions - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptionsAdditionalInformationDetails Composition of Certain Financial Statement Captions - Additional Information (Details) Details 53 false false R54.htm 995905 - Disclosure - Composition of Certain Financial Statement Captions - Intangible Assets, Net (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureCompositionOfCertainFinancialStatementCaptionsIntangibleAssetsNetDetails Composition of Certain Financial Statement Captions - Intangible Assets, Net (Details) Details 54 false false R55.htm 995915 - Disclosure - Composition of Certain Financial Statement Captions - Future Amortization Expense on Intangible Assets (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureCompositionOfCertainFinancialStatementCaptionsFutureAmortizationExpenseOnIntangibleAssetsDetails Composition of Certain Financial Statement Captions - Future Amortization Expense on Intangible Assets (Details) Details 55 false false R56.htm 995925 - Disclosure - Composition of Certain Financial Statement Captions - Accounts Payable and Accrued Expenses (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCompositionOfCertainFinancialStatementCaptionsAccountsPayableAndAccruedExpensesDetails Composition of Certain Financial Statement Captions - Accounts Payable and Accrued Expenses (Details) Details 56 false false R57.htm 995935 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 57 false false R58.htm 995945 - Disclosure - Commitments and Contingencies - Summary of Future Minimum Annual Lease Payments under Operating Leases (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFutureMinimumAnnualLeasePaymentsUnderOperatingLeasesDetails Commitments and Contingencies - Summary of Future Minimum Annual Lease Payments under Operating Leases (Details) Details 58 false false R59.htm 995965 - Disclosure - Commitments and Contingencies - Summary of Lease Costs (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesSummaryOfLeaseCostsDetails Commitments and Contingencies - Summary of Lease Costs (Details) Details 59 false false R60.htm 995975 - Disclosure - License Agreements - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetails License Agreements - Additional Information (Details) Details 60 false false R61.htm 995985 - Disclosure - Term Loan Obligations - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureTermLoanObligationsAdditionalInformationDetails Term Loan Obligations - Additional Information (Details) Details 61 false false R62.htm 995995 - Disclosure - Line of Credit Facility - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureLineOfCreditFacilityAdditionalInformationDetails Line of Credit Facility - Additional Information (Details) Details 62 false false R63.htm 996005 - Disclosure - Grant Revenue - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureGrantRevenueAdditionalInformationDetails Grant Revenue - Additional Information (Details) Details 63 false false R64.htm 996015 - Disclosure - Biocept Asset Acquisitions - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureBioceptAssetAcquisitionsAdditionalInformationDetails Biocept Asset Acquisitions - Additional Information (Details) Details 64 false false R65.htm 996025 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 65 false false R66.htm 996035 - Disclosure - Income Taxes - Summary of Net Loss Before Income Tax Provision (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetLossBeforeIncomeTaxProvisionDetails Income Taxes - Summary of Net Loss Before Income Tax Provision (Details) Details 66 false false R67.htm 996045 - Disclosure - Income Taxes - Reconciliation of Income Tax Benefit At U.S. Federal Statutory Rate to Provision for Income Taxes (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxBenefitAtUsFederalStatutoryRateToProvisionForIncomeTaxesDetails Income Taxes - Reconciliation of Income Tax Benefit At U.S. Federal Statutory Rate to Provision for Income Taxes (Details) Details 67 false false R68.htm 996065 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Deferred Tax Assets and Liabilities (Details) Details 68 false false R69.htm 996075 - Disclosure - Income Taxes - Unrecognized Tax Benefits Activity (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesUnrecognizedTaxBenefitsActivityDetails Income Taxes - Unrecognized Tax Benefits Activity (Details) Details 69 false false R70.htm 996085 - Disclosure - Employee Benefit Plan - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails Employee Benefit Plan - Additional Information (Details) Details 70 false false R71.htm 996095 - Disclosure - Stockholders' Equity - Preferred Stock (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockholdersEquityPreferredStockDetails Stockholders' Equity - Preferred Stock (Details) Details 71 false false R72.htm 996105 - Disclosure - Stockholders' Equity - Common stock (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockholdersEquityCommonStockDetails Stockholders' Equity - Common stock (Details) Details 72 false false R73.htm 996115 - Disclosure - Stockholders' Equity - Summary of Warrants Outstanding (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockholdersEquitySummaryOfWarrantsOutstandingDetails Stockholders' Equity - Summary of Warrants Outstanding (Details) Details 73 false false R74.htm 996125 - Disclosure - Stock-based Compensation - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails Stock-based Compensation - Additional Information (Details) Details 74 false false R75.htm 996135 - Disclosure - Stock-based Compensation - Stock Option Activity (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationStockOptionActivityDetails Stock-based Compensation - Stock Option Activity (Details) Details 75 false false R76.htm 996145 - Disclosure - Stock-based Compensation - Weighted-average Assumptions (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationWeightedaverageAssumptionsDetails Stock-based Compensation - Weighted-average Assumptions (Details) Details 76 false false R77.htm 996155 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Activity (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsActivityDetails Stock-Based Compensation - Summary of Restricted Stock Units Activity (Details) Details 77 false false R78.htm 996165 - Disclosure - Stock-based Compensation - Summary of Share-Based Compensation Recognized (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfSharebasedCompensationRecognizedDetails Stock-based Compensation - Summary of Share-Based Compensation Recognized (Details) Details 78 false false R79.htm 996175 - Disclosure - Segment Information - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 79 false false R80.htm 996185 - Disclosure - Segment Information - Schedule of Segment Expenses (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/DisclosureSegmentInformationScheduleOfSegmentExpensesDetails Segment Information - Schedule of Segment Expenses (Details) Details 80 false false R81.htm 996195 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.plustherapeutics.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 81 false false All Reports Book All Reports pstv-20251231.htm pstv-20251231.xsd http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false